Aim The review summarizes the recent empirical evidence on the efficacy, safety, and
community perception of malaria vaccines in Africa. Methods Academic Search Complete …

Background The candidate malaria vaccine RTS, S/AS01 is being evaluated in order to
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …

Malaria continues to be a worldwide leading cause of morbidity and mortality, and the
development of an effective malaria vaccine remains a research imperative. Of the multiple …

Abstract Background The RTS, S/AS malaria candidate vaccine is being developed with the
intent to be delivered, if approved, through the Expanded Programme on Immunization (EPI) …

A Malaria Vaccine for Africa — An Important Step in a Century-Long Quest | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Background This study advances the clinical development of the RTS, S/AS01B candidate
malaria vaccine to malaria endemic populations. As a primary objective it compares the …

Background The target delivery channel of RTS, S candidate malaria vaccines in malaria-
endemic countries in Africa is the World Health Organisation Expanded Program on …

ABSTRACT Introduction: RTS, S/AS01 is currently the most advanced malaria vaccine but
provides incomplete, short-term protection. It was developed for use within the expanded …

ABSTRACT The RTS, S/AS01 malaria vaccine received a positive scientific opinion from the
European Medicines Agency in July 2015. The World Health Organization recommended …

RTS, S is the most advanced candidate vaccine against human malaria. During its
remarkable journey from conception and design in the early 1980s to the multicenter Phase …